Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes

NCT02319967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 373

Last updated 2019-06-19

Study results available
· View outcomes & findings →

Summary

Chicago is an epicenter for asthma health disparities in the U.S., with African-American children 5-11 yrs bearing a disproportionate share of the burden. Among the most visible of these disparities is the high rate of visits to the Emergency Department (ED) for uncontrolled asthma. Clinical uncertainties regarding the real-world effectiveness of guideline recommendations for ED discharge and strategies to reduce environmental triggers at home contribute to practice variation and poor adherence to guidelines. The CHICAGO Plan tests both ED- and home-level interventions to improve clinically meaningful outcomes in a minority pediatric ED population with uncontrolled asthma.

Conditions

Interventions

BEHAVIORAL

CAPE

Decision support and communication tool to promote guideline-recommended care by providers and use of such care by children/caregivers

BEHAVIORAL

CHW home visits

Home visits by community health workers (CHW) to assist children and their caregivers to implement the CAPE and other guideline-recommended competencies.

Sponsors & Collaborators

  • Sinai Health System

    collaborator OTHER
  • Cook County Health & Hospitals System

    collaborator OTHER
  • Rush University Medical Center

    collaborator OTHER
  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER
  • University of Chicago

    collaborator OTHER
  • Chicago Department of Public Health

    collaborator OTHER_GOV
  • Respiratory Health Association

    collaborator UNKNOWN
  • Chicago Asthma Consortium

    collaborator UNKNOWN
  • Illinois Institute of Technology

    collaborator OTHER
  • Illinois Emergency Department Asthma Surveillance Project

    collaborator UNKNOWN
  • Patient-Centered Outcomes Research Institute

    collaborator OTHER
  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Jerry A Krishnan, MD, PhD · University of Illinois at Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02319967 on ClinicalTrials.gov